Congress Frets Over Slow Pace of Biosimilar Licensing
Thu, 04 Feb 2016 00:00:00 -0500
FDA came under fire today from members of the House of Representatives who were critical of the agency's seemingly slow pace in approving biosimilar drugs and failure to provide manufacturers with timely guidance on developing these biological products.
More Federal Dollars Proposed for Addressing Opioid Abuse
Wed, 03 Feb 2016 00:00:00 -0500
In the continuing struggle to address the nation's opioid overdose epidemic, the White House on Tuesday announced that President Barack Obama wants the federal government to fund more efforts to help people who have an opioid-use disorder.
Hospital Pharmacies Cope With Surge in Drug Prices
Mon, 01 Feb 2016 00:00:00 -0500
When the staff at Baystate Health in Massachusetts observed an alarming series of price increases for the vasodilator drug nitroprusside last year, the integrated health system took a strong step in response.
Standards on Handling Hazardous Drugs Issued by USP
The United States Pharmacopeial Convention (USP) today published the nation's first set of authoritative standards on the handling of hazardous drugs by healthcare personnel.
Elbasvir–Grazoprevir Approved for Chronic Hepatitis C Infection
Fri, 29 Jan 2016 00:00:00 -0500
FDA on January 28 approved the marketing of elbasvir–grazoprevir oral tablets for the treatment of chronic hepatitis C virus (HCV) genotype 1 and 4 infection in adults.